Schrodinger Inc (SDGR)

Currency in USD
18.77
+0.61(+3.36%)
Closed·
18.78+0.01(+0.05%)
·
SDGR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.9518.94
52 wk Range
10.9523.02
Key Statistics
Prev. Close
18.77
Open
18.02
Day's Range
17.95-18.94
52 wk Range
10.95-23.02
Volume
1.2M
Average Vol. (3m)
1.29M
1-Year Change
0.7515%
Book Value / Share
4.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SDGR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.57
Upside
+9.60%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Schrodinger Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 20.57
(+9.60% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Hold17.00-9.43%19.00MaintainMay 14, 2026
KeyBanc
Buy20.00+6.55%25.00MaintainApr 13, 2026
UBS
Hold13.00-30.74%18.00MaintainMar 17, 2026
BMO Capital
Buy24.00+27.86%32.00MaintainFeb 26, 2026
TD Cowen
Buy24.00+27.86%-MaintainJan 13, 2026

Schrodinger Inc Earnings Call Summary for Q2/2026

  • Schrödinger reported Q2 2026 EPS of $0.08 vs. expected loss of $0.49; revenue hit $58.9M, beating estimates of $48.08M by 22.5%.
  • Annual contract value rose 27% YoY to $29.6M; hosted software revenue reached 47% of total software revenue, up from 31% prior year.
  • Company raised full-year drug discovery revenue guidance to $65M-$75M from $55M-$65M following $10M Ajax Therapeutics milestone payment.
  • Management maintained 2026 ACV guidance of $218M-$228M (10-15% growth); expects to reach 75% hosted revenue by end of 2028.
  • New AI products Bunsen and Predictive Tox driving growth; shares rose 4.86% to $16.41, adding 3.05% after-hours to $16.90.
Last Updated: 08/05/2026, 05:12 PM
Read Full Transcript
Schrodinger investor slides for Q2/2026
Schrödinger Q2 2026 slides
Last Update: Aug 05, 2026
See full investor slides

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
0.08 / -0.49
Revenue / Forecast
58.89M / 48.08M
EPS Revisions
Last 90 days

SDGR Income Statement

Compare SDGR to Peers and Sector

Metrics to compare
SDGR
Peers
Sector
Relationship
P/E Ratio
−25.8x−5.7x−0.4x
PEG Ratio
−0.37−0.120.00
Price / Book
4.3x2.6x2.6x
Price / LTM Sales
5.4x7.6x3.1x
Upside (Analyst Target)
6.6%34.4%48.2%
Fair Value Upside
Unlock5.8%5.8%Unlock

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Employees
850

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
29.48M39.40%553.29M
Other Institutional Investors
42.80M57.22%803.44M
Public Companies & Retail Investors
2.52M3.37%47.38M
Total
74.81M100.00%1.4B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bill & Melinda Gates Foundation Trust21.58%16,145,857303,058
BlackRock, Inc.12.94%9,678,560181,667

People Also Watch

138.74
SPCX
+4.23%
325.15
COHR
-14.24%
38.78
ONON
+3.28%
217.55
NVDA
-2.86%

FAQ

What Is the Schrodinger (SDGR) Stock Price Today?

The Schrodinger stock price today is 18.77 USD.

What Stock Exchange Does Schrodinger Trade On?

Schrodinger is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Schrodinger?

The stock symbol for Schrodinger is "SDGR."

What Is the Schrodinger Market Cap?

As of today, Schrodinger market cap is 1.40B USD.

What Is Schrodinger's Earnings Per Share (TTM)?

The Schrodinger EPS (TTM) is -0.74.

When Is the Next Schrodinger Earnings Date?

Schrodinger will release its next earnings report on Nov 11, 2026.

From a Technical Analysis Perspective, Is SDGR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Schrodinger Stock Split?

Schrodinger has split 0 times.

How Many Employees Does Schrodinger Have?

Schrodinger has 850 employees.

What is the current trading status of Schrodinger (SDGR)?

As of Aug 11, 2026, Schrodinger (SDGR) is trading at a price of 18.77 USD, with a previous close of 18.77 USD. The stock has fluctuated within a day range of 17.95 USD to 18.94 USD, while its 52-week range spans from 10.95 USD to 23.02 USD.

What Is Schrodinger (SDGR) Price Target According to Analysts?

The average 12-month price target for Schrodinger is 20.57 USD, with a high estimate of 30 USD and a low estimate of 13 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +9.60% Upside potential.

What Is the SDGR Premarket Price?

SDGR's last pre-market stock price is 18.78 USD. The pre-market share volume is 740.00, and the stock has decreased by 0.01, or 0.05%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.